Video
Advantages of transperineal biopsies over transrectal biopsies
Author(s):
Video Player is loading.
In this video, Matthew J. Allaway, MD, assesses the differences between the transrectal and transperineal approaches to prostate biopsy and the overall advantage of the transperineal biopsy in detecting cancer and preventing infection. Allaway is the founder and president of Perinealogic, and a urologist and managing partner at Urology Associates, Cumberland, Maryland.
Related Videos
John Gore, MD, on radical cystectomy vs bladder-sparing therapy for NMIBC
Jason Hafron, MD, outlines AUA 2025 session on clinical trial recruitment
Study data point to gender disparities in oncology research citations
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
Ekene Enemchukwu, MD, on guideline-associated trends in OAB therapy use
Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
Karyn S. Eilber, MD, on patient counseling for onabotA treatment for OAB
Optimizing onabotA for OAB: What are some common misconceptions?
Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease
Nitin Yerram, MD, highlights new resource center for patients with renal cell carcinoma
Related Content
